REG - AdvancedAdvT Limited - Purchase of Own Shares

AdvancedAdvTAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260310:nRSJ9483Va&default-theme=true

RNS Number : 9483V  AdvancedAdvT Limited  10 March 2026

This announcement contains inside information

for the purposes of UK Market Abuse Regulation.

 

10 March 2026

AdvancedAdvT Limited

Purchase of Own Shares

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", the "Group", the "Company"), the
international software solutions provider for the business solutions,
healthcare compliance, and human capital management sectors, announces that
further to the confirmation of its intention to implement a share buyback
programme, as set out in its announcement on 4 March 2026, on  9 March 2026
it had purchased a further 100,000 of its ordinary shares of no par value in
the capital of the Company ("Ordinary Shares") at an average price of 157.875
pence per share. The Ordinary Shares purchased will be held in treasury.

 

Following this purchase, the cumulative number of Ordinary Shares bought under
this programme now totals 125,000.

 

Aggregated information

 

 Date of purchase                       9 March 2026
 Number of Ordinary Shares purchased    100,000
 Highest price paid per Ordinary Share  158.5 pence
 Lowest price paid per Ordinary Share   157.0 pence
 Volume weighted average price paid     157.875 pence

 

Transaction details

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law pursuant to the
European Union (Withdrawal) Act 2018), a detailed breakdown of individual
trades is available below:

 

 

 Number of Ordinary Shares purchased  Transaction price (GBp)  Time of transaction  Trading venue
 25,000                               158.5 pence              12.33.33 p.m.        AIMX
 25,000                               158.5 pence              12.32.24 p.m.        AIMX
 25,000                               157.0 pence              09.55.23 a.m.        AIMX
 25,000                               157.5 pence              08.12.23 a.m.        AIMX

 

Total voting rights

 

Following the purchase, the Company's total issued share capital will consist
of 137,125,806 Ordinary Shares each carrying one voting right, of which
125,000 Ordinary Shares are held in treasury. Therefore, the total number of
Ordinary Shares carrying voting rights will be 137,000,806. This figure may be
used by shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or a change
to their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.

 

 

 

The person responsible for arranging the release of this Announcement

on behalf of the Company is Gavin Hugill, Chief Financial Officer.

 

Enquiries:

 AdvancedAdvT Limited
 Vin Murria, Chairperson

 Gavin Hugill, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)  Tel: 020 7496 3000
 Philip Davies / James Fischer

 KK Advisory (Investor Relations)                       Tel: 020 7039 1901
 Kam Bansil

 

Note to Editors

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across
two business transformational areas: business solutions & healthcare
compliance, and human capital management.

AdvT is an agent for change. The Group enables the delivery of Artificial
Intelligence ("AI"), data analytics and business intelligence, all of which
are key future drivers for growth in these sectors where long term
digitisation trends are set to transform the workplace for professionals.

AdvT is developing both organically and through acquisitions, by expanding its
presence across adjacent markets, geographical boundaries and digital sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSSSUESUEMSEFD



            Copyright 2019 Regulatory News Service, all rights reserved